GEOFF MCDONOUGH - 15 Oct 2025 Form 4 Insider Report for Generation Bio Co. (GBIO)

Signature
/s/ Shawna-Gay White, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
15 Oct 2025
Net transactions value
-$1,040
Form type
4
Filing time
17 Oct 2025, 16:05:12 UTC
Previous filing
17 Jul 2025
Next filing
21 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MCDONOUGH GEOFF PRESIDENT AND CEO, Director C/O GENERATION BIO CO., 301 BINNEY ST, CAMBRIDGE /s/ Shawna-Gay White, Attorney-in-Fact 17 Oct 2025 0001732701

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBIO Common Stock Options Exercise +527 +0.39% 136,991 15 Oct 2025 Direct F1, F2
transaction GBIO Common Stock Tax liability $1,040 -155 -0.11% $6.71 136,836 15 Oct 2025 Direct F1
holding GBIO Common Stock 22,646 15 Oct 2025 By 2018 Trust F1, F3
holding GBIO Common Stock 27,500 15 Oct 2025 By 2020 Trust F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Restricted Stock Units Options Exercise $0 -527 -17% $0.000000 2,636 15 Oct 2025 Common Stock 527 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amounts reported in this Form 4 reflect the one-for-10 reverse stock split effected by the issuer on July 21, 2025.
F2 Each restricted stock unit represents the right to receive one share of the company's common stock.
F3 The securities are directly held by the McDonough Family 2018 Irrevocable Trust, or the 2018 Trust. The reporting person is the settlor of the 2018 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2018 Trust, and the 2018 Trust is for the benefit of Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2018 Trust.
F4 The securities are directly held by the McDonough Family 2020 Irrevocable Trust, or the 2020 Trust. The reporting person is the settlor of the 2020 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2020 Trust, and the 2020 Trust is for the benefit of Allison, Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2020 Trust.
F5 On January 20, 2023, the reporting person was granted 8,437 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.